Trials / Completed
CompletedNCT06659575
Prevalence of Sleep Disturbances in Elderly People Hospitalized in Medicine, Psychiatry and Rehabilitation Departments: TOPASE Prospective Study, RIPH 3
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 104 (actual)
- Sponsor
- University Hospital, Angers · Other Government
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Objectives and evaluation criteria: The main objective of this study is to evaluate changes in sleep quality in patients aged 60 and over since their admission to a medical, psychiatric or medical and rehabilitation ward in one of the GHT 49 healthcare establishments. The primary endpoint will be the difference between the usual sleep quality score and the sleep quality score during hospitalization, according to the Spiegel scale. Research plan and procedure: Patients participating in the study will be asked to complete a questionnaire including the Spiegel scale at two points during their hospitalization: * Day 0: questionnaire n°1 to assess sleep quality on the night prior to hospitalization, including the Spiegel scale. * Day 2 (morning of the third day of hospitalization): during the morning, depending on the organization of the ward, questionnaire n°2 to assess sleep quality during the previous night, including the Spiegel scale. Number of research participants: As the study is essentially descriptive, aimed at taking stock of the situation, the calculation of the number of patients to be included was not based on a hypothesis test. Pragmatically, the investigator plan to include the maximum number of patients meeting the criteria during the targeted week. Given the number of beds in the GHT 49 establishments in the departments concerned, and the average number of new admissions, the investigator estimate that 200 patients could be included. Research duration: Inclusion period: 5 days, Monday to Friday Participation period: 3 days (from day 0 to day 2) Study duration: 7 days
Conditions
Timeline
- Start date
- 2025-01-20
- Primary completion
- 2025-01-26
- Completion
- 2025-01-26
- First posted
- 2024-10-26
- Last updated
- 2025-08-28
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06659575. Inclusion in this directory is not an endorsement.